4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-002457
Chairman and CEO bought 394 shares at an average $4.54 ($1,790)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2021-12-01 | Purchase | +18 | $4.14 | $75 | 5,770,187 | D |
| KAZIMI A J Chairman and CEO | 2021-12-02 | Purchase | +18 | $3.84 | $69 | 5,770,205 | D |
| KAZIMI A J Chairman and CEO | 2021-12-03 | Purchase | +18 | $4.47 | $80 | 5,770,223 | D |
| KAZIMI A J Chairman and CEO | 2021-12-06 | Purchase | +18 | $4.46 | $80 | 5,770,241 | D |
| KAZIMI A J Chairman and CEO | 2021-12-07 | Purchase | +18 | $5.61 | $101 | 5,770,259 | D |
| KAZIMI A J Chairman and CEO | 2021-12-08 | Purchase | +18 | $6.15 | $111 | 5,770,277 | D |
| KAZIMI A J Chairman and CEO | 2021-12-09 | Purchase | +18 | $5.81 | $105 | 5,770,295 | D |
| KAZIMI A J Chairman and CEO | 2021-12-10 | Purchase | +18 | $4.82 | $87 | 5,770,313 | D |
| KAZIMI A J Chairman and CEO | 2021-12-13 | Purchase | +30 | $4.36 | $131 | 5,770,343 | D |
| KAZIMI A J Chairman and CEO | 2021-12-14 | Purchase | +30 | $4.28 | $128 | 5,770,373 | D |
| KAZIMI A J Chairman and CEO | 2021-12-15 | Purchase | +30 | $4.29 | $129 | 5,770,403 | D |
| KAZIMI A J Chairman and CEO | 2021-12-16 | Purchase | +50 | $4.53 | $227 | 5,770,453 | D |
| KAZIMI A J Chairman and CEO | 2021-12-17 | Purchase | +50 | $4.17 | $209 | 5,770,503 | D |
| KAZIMI A J Chairman and CEO | 2021-12-20 | Purchase | +60 | $4.33 | $260 | 5,770,563 | D |
| Open-market purchases · 394 sh · avg $4.54 · $1,790 | |||||||
Loading xslF345X03/doc4.xml…